Evidence map›Paper›PMID 37996730›Full record

ReviewMolecular neurobiology2024

Therapeutic Targeting of Krüppel-Like Factor 4 and Its Pharmacological Potential in Parkinson's Disease: a Comprehensive Review.

Mohammad Yasin Zamanian, Maryam Golmohammadi, Rana Sherdil Amin, Ghadeer Sabah Bustani, Rosario Mireya Romero-Parra, Rahman S Zabibah, Tuba Oz, Abduladheem Turki Jalil, Afsaneh Soltani, Małgorzata Kujawska

Open access · hybridAbstract readReview
In one paragraph

Review in Molecular neurobiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. International journal of molecular sciences · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 5 countries.

Mohammad Yasin ZamanianNeurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, 6718773654, Iran.
Maryam GolmohammadiSchool of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, 1988873554, Iran.
Rana Sherdil AminSharif Medical & Dental College, Lahore, Pakistan.
Ghadeer Sabah BustaniCollege of Dentistry, The Islamic University, Najaf, Iraq.
Rosario Mireya Romero-ParraGeneral Studies, Universidad Continental, Lima, Perú.
Rahman S ZabibahMedical Laboratory Technology Department, College of Medical Technology, The Islamic University, Najaf, Iraq.
Tuba OzDepartment of Toxicology, Poznan University of Medical Sciences, Rokietnicka 3, 60-806, Poznan, Poland.
Abduladheem Turki JalilMedical Laboratories Techniques Department, Al-Mustaqbal University College, Babylon, Hilla, 51001, Iraq.
Afsaneh SoltaniSchool of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, 1988873554, Iran. afsanehstn74@gmail.com.
Małgorzata KujawskaDepartment of Toxicology, Poznan University of Medical Sciences, Rokietnicka 3, 60-806, Poznan, Poland. kujawska@ump.edu.pl.ORCID http://orcid.org/0000-0002-5306-9904
Iraqi University · IQPoznan University of Medical Sciences · PLShahid Beheshti University of Medical Sciences · IRAlsalam University College · IQCMH Lahore Medical College and Institute of Dentistry · PKHamedan University of Medical Sciences · IRUniversidad Continental · PE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Krüppel-like factor 4 (KLF4), a zinc finger transcription factor, is found in different human tissues and shows diverse regulatory activities in a cell-dependent manner. In the brain, KLF4 controls various neurophysiological and neuropathological processes, and its contribution to various neurological diseases has been widely reported. Parkinson's disease (PD) is an age-related neurodegenerative disease that might have a connection with KLF4. In this review, we discussed the potential implication of KLF4 in fundamental molecular mechanisms of PD, including aberrant proteostasis, neuroinflammation, apoptosis, oxidative stress, and iron overload. The evidence collected herein sheds new light on KLF4-mediated pathways, which manipulation appears to be a promising therapeutic target for PD management. However, there is a gap in the knowledge on this topic, and extended research is required to understand the translational value of the KLF4-oriented therapeutical approach in PD.

Indexed as

Kruppel-Like Factor 4Kruppel-Like Transcription FactorsParkinson DiseaseAnimalsApoptosisHumansMolecular Targeted TherapyOxidative StressKLF4 protein, humanKruppel-Like Factor 4Kruppel-Like Transcription FactorsApoptosisAutophagyKLF4NeuroinflammationOxidative stressParkinson’s disease

Identifiers

PMID37996730
PMCPMC11087351
OpenAlexW4388976211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.